Philadelphia-area life sciences companies with the largest stock, market cap declines in first half of 2022

Midsize and startup drug developers in the Philadelphia region saw their market capitalization drop by nearly $3.7 billion during the first half of 2022.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news